Combination of 22-oxa-1,25-dihydroxyvitamin D3, a vitamin D3 derivative, with vitamin K2 (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60 cells

Leukemia

Volumn 16, Issue 8, 2002, Pages 1519-1527

  Funato, K ^a   Miyazawa, K ^a   Yaguchi, M ^a   Gotoh, A ^a   Ohyashiki, K ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Differentiation; Leukemia cell; Vitamin D3; Vitamin K2

Indexed keywords

22 OXACALCITRIOL; CALCITRIOL; CASPASE 3; COLECALCIFEROL DERIVATIVE; ESTERASE; FARNOQUINONE; MEMBRANE ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CELL STRUCTURE; CONTROLLED STUDY; DATA ANALYSIS; DRUG POTENTIATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; LEUKEMIA CELL; MONOCYTE; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0036054309     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402614     Document Type: Article

References (41)

1. All-trans-retinoic acid in acute promyelocytic leukemia
2. Acute promyelocytic leukemia: A curable disease
3. Leukemia cell differentiation: Cellular and molecular interaction of retinoids and vitamin D
4. Vitamin K2 and its derivatives induce apoptosis in leukemia cells and enhance of all-trans retinoic acid
5. Vitamin K2 selectively induces apoptosis of blastic cells in myelodysplastic syndrome: Flow cytometric detection of apoptotic cells using APO2.7 monoclonal antibody
6. Vitamin K2 therapy for myelodysplastic syndrome (MDS) and post-MDS acute myeloid leukemia: Information through a questionnaire survey of multi-center pilot studies in Japan
7. Successful therapy of myelodysplastic syndrome with menatetrenone, a vitamin K2 analog
8. Vitamin K2 combined with all-trans retinoic acid induced complete remission of relapsing acute promyelocytic leukemia
9. Novel role of vitamin K2: A potent inducer of differentiation of various human myeloid leukemia cell lines
10. Apoptosis/differentiation-inducing effects of vitamin K2 on HL-60 cells: Dichotomous nature of vitamin K2 in leukemia cells
11. Differentiation of mouse myeloid leukemia cells induced by 1α, 25-dihydroxyvitamin D3
12. Southern California Leukemia Group. 1,25-Dihydroxyvitamin D3 in vitro and in vivo effects on human preleukemia and leukemic cells
13. Vitamin D treatment in myelodysplastic syndromes
14. The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion
15. A novel vitamin D3 analog, 22-oxa-1.25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia
16. Vitamin D analogs: Perspectives for treatment
17. Combination of granulocyte colony-stimulating factor and low-dose cytosine arabinoside further enhances myeloid differentiation in leukemia cells in vitro
18. A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells
19. Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton. A trial of the development of vitamin D compounds which exhibit potent differentiation-inducing activity without inducing hypercalcemia
20. p27KIP1 accumulation is associated with retinoic-induced neuroblastoma differentiation: Evidence of a decreased proteasome-dependent degradation
21. Overexpression of p21WAF1/CIP1 induces cell differentiation and growth inhibition in a human glioma cell line
22. Inducted differentiation of U937 cells by 1,25-dihydroxyvitamin D3 involves cell cycle arrest in G1 that is preceded by a transient proliferative burst and an increase in cyclin expression
23. Mannosylerythritol lipid is a potent inducer of apoptosis and differentiation of mouse melanoma cells in culture
24. Induction of differentiation in normal human keratinocytes by adenovirus-mediated introduction of the eta and delta isoforms of protein kinase C
25. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors
26. Stem cell factor inhibits erythroid differentiation by modulating the activity of G1-cyclin-dependent kinase complexes: A role for p27 in erythroid differentiation coupled G1 arrest
27. Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation
28. Vitamin D analogs, 20-Epi-22-oxa-24a, 26a,27a,-trihomo-1alpha,25(OH)2-vitamin D3, 1,24(OH)2-22-ene-24-cyclopropyl-vitamin D3 and 1alpha,25(OH)2-lumisterol3 signaling pathways, involving calcium and calpain
29. 1alpha,25-dihydroxyvitamin D(3)-induced myeloid cell differentiation is regulated by a vitamin D receptor-phosphatidylinositol 3-kinase signaling complex
30. Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1, 25-dihydroxyvitamin D3-induced differentiation of HL60 cells
31. Transcriptional synergism between the vitamin D3 receptor and other nonreceptor transcription factors
32. Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog
33. Vitamin D receptor and nuclear receptor coactivators: Crucial interactions in vitamin D-mediated transcription
34. Actions of vitamin D3, analogs on human prostate cancer cell lines: Comparison with 1,25-dihydroxyvitamin D3
35. Nuclear vitamin K2 binding protein in human osteoblasts: Homologue to glyceral-dehyde-3-phosphate dehydrogenase
36. Vitamin K-dependent γ-carboxylation of the 1,25-dehydroxyvitamin D3 receptor
37. Apoptosis inhibitory activity of cytoplasmic p21 (Cip1/WAF1) in monocytic differentiation
38. Sustained hematological response to high-dose oral alfacalcidol in patients with myelodysplastic syndromes
39. A randomized study of alfacalcidol in the refractory myelodysplastic anaemias. A Japanese cooperative study
40. Effect of 22-oxacalcitol on bone histology of hemodialzed patients with severe secondary hyperparathyroidism
41. Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study